These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 6899739)

  • 41. In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole.
    Santoro J; Kaye D; Levison ME
    Antimicrob Agents Chemother; 1976 Jul; 10(1):188-90. PubMed ID: 984752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Bacteroides fragilis. Its isolation and antibiotic sensitivity].
    Cancet B; Nadaud M
    Ann Biol Clin (Paris); 1976; 34(2):133-7. PubMed ID: 970703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the bactericidal activity of clindamycin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
    Stratton CW; Weeks LS; Aldridge KE
    Diagn Microbiol Infect Dis; 1991; 14(5):377-82. PubMed ID: 1797454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of inoculum size and medium on activity of seven antimicrobial agents against Bacteroides fragilis strains.
    Wexler HM; Reeves D; Finegold SM
    Clin Ther; 1989; 11(6):828-33. PubMed ID: 2611824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of tigecycline against Bacteroides species.
    Betriu C; Culebras E; Gómez M; Rodríguez-Avial I; Picazo JJ
    J Antimicrob Chemother; 2005 Aug; 56(2):349-52. PubMed ID: 15951353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimicrobial susceptibility patterns and resistance transferability among Bacteroides fragilis group isolates from patients with appendicitis in Bali, Indonesia.
    Suata K; Watanabe K; Ueno K; Homma M
    Clin Infect Dis; 1993 Apr; 16(4):561-6. PubMed ID: 8513066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evolution of antimicrobial susceptibility in isolates of the Bacteroides fragilis group in Spain.
    García-Rodríguez JE; García-Sánchez JE
    Rev Infect Dis; 1990; 12 Suppl 2():S142-51. PubMed ID: 2305180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bacteroides fragilis group: trends in resistance.
    Fille M; Mango M; Lechner M; Schaumann R
    Curr Microbiol; 2006 Feb; 52(2):153-7. PubMed ID: 16450067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [In vitro activity of the oxa-beta-lactam LY 127935 against Bacteroides fragilis and other anaerobic gram-negative rods (author's transl)].
    Werner H; Krasemann C
    Infection; 1980; 8 Suppl 3():S 342-6. PubMed ID: 6447673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Susceptibility of the species of genus bacteroides recently isolated from clinical specimens to 20 antimicrobial agents.
    Nasu M; Nakatomi M; Saito A; Hara K
    Arzneimittelforschung; 1981; 31(5):764-70. PubMed ID: 7196732
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bacteroides fragilis resistant to metronidazole, clindamycin and cefoxitin.
    Brogan O; Garnett PA; Brown R
    J Antimicrob Chemother; 1989 Apr; 23(4):660-2. PubMed ID: 2745269
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparative susceptibility of anaerobic bacteria to ticarcillin, cefoxitin, metronidazole, and related antimicrobial agents.
    Henderson DK; Chow AW; Guze LB
    Antimicrob Agents Chemother; 1977 Apr; 11(4):679-82. PubMed ID: 856019
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimicrobial therapy of postpartum endomyometritis. I. Comparative susceptibility of mezlocillin and other antibiotics to genital anaerobic bacteria.
    Sorrell TC; Marshall JR; Chow AW
    Am J Obstet Gynecol; 1981 Oct; 141(3):242-5. PubMed ID: 6456667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiotic sensitivity of the Bacteroides fragilis group in Denmark. Danish Study Group.
    Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
    APMIS; 1993 Sep; 101(9):727-31. PubMed ID: 8240792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of kill-kinetic studies with agar and broth microdilution methods for determination of antimicrobial activity of selected agents against members of the Bacteroides fragilis group.
    Stratton CW; Weeks LS; Aldridge KE
    J Clin Microbiol; 1987 Apr; 25(4):645-9. PubMed ID: 3571474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Bacteriological and clinical studies on metronidazole in Bacteroides fragilis infections (author's transl)].
    Shimada K; Inamatsu T; Sato K
    Jpn J Antibiot; 1979 Feb; 32(2):191-4. PubMed ID: 439390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.
    Brook I; Coolbaugh JC; Walker RI; Weiss E
    Antimicrob Agents Chemother; 1984 Jan; 25(1):71-7. PubMed ID: 6142680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of metronidazole, chloramphenicol, clindamycin and penicillin G on growth and neuraminidase activity of Bacteroides fragilis.
    Ferreira MC; Domingues RM; de Uzeda M
    J Antimicrob Chemother; 1989 Aug; 24(2):157-64. PubMed ID: 2793640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sensitivity of Bacteroides species to modern antimicrobial preparations.
    Závadová M; Tynková S; Adensámová J; Brezinová L
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(1):51-9. PubMed ID: 6602163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.